Search

Search Constraints

You searched for: Author/Creator Sachdev, Sean

Search Results

1. 892 Validation of Docetaxel as a Radiosensitizer in High-Risk Meningiomas Based on DNA Methylation Profiling. (April 2023)

2. C-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target. (December 2017)

3. CMET-11. RESPONSE TO STEREOTACTIC RADIOSURGERY FOR MULTIPLE BRAIN METASTASES BASED ON HISTOLOGY-SPECIFIC SUBTYPE STATUS. (11th November 2019)

4. CTIM-12. A PHASE 1 TRIAL OF IMMUNORADIOTHERAPY WITH THE IDO ENZYME INHIBITOR (BMS-986205) AND NIVOLUMAB IN PATIENTS WITH NEWLY DIAGNOSED MGMT PROMOTER UNMETHYLATED IDHwt GLIOBLASTOMA. (12th November 2021)

6. Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient. Issue 1 (15th March 2021)

7. Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. Issue 3 (17th August 2022)

9. Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas. Issue 4 (10th November 2019)

10. EXTH-36. ELECTROCONVULSIVE SEIZURE-INDUCED CHANGES IN THE TUMOR MICROENVIRONMENT PROMOTE SURVIVAL IN GLIOMA-BEARING MICE. (12th November 2021)